_:nf91e8901b5f340c9af60f1fe5c573f09xb3
<http://schema.org/position>
<https://invivoscribe.com/invivoscribe-submits-the-leukostrat-cdx-flt3-mutation-assay-to-support-daiichi-sankyo-submission-for-quizartinib-in-japan/>